Sulfonyl amide derivatives for the treatment of abnormal cell growth
申请人:Pfizer, Inc.
公开号:US10450297B2
公开(公告)日:2019-10-22
The present invention relates to a compound of the formula I
wherein R1 to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.
本发明涉及一种式 I 的化合物
其中 R1 至 R6、A、B、n 和 m 如本文所定义。这种新型磺酰基酰胺衍生物可用于治疗哺乳动物的异常细胞生长,如癌症。本发明还涉及使用此类化合物治疗哺乳动物(尤其是人类)细胞异常生长的方法,以及含有此类化合物的药物组合物。
US7928109B2
申请人:——
公开号:US7928109B2
公开(公告)日:2011-04-19
US8247411B2
申请人:——
公开号:US8247411B2
公开(公告)日:2012-08-21
US8440822B2
申请人:——
公开号:US8440822B2
公开(公告)日:2013-05-14
SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
申请人:Luzzio Michael Joseph
公开号:US20090054395A1
公开(公告)日:2009-02-26
The present invention relates to a compound of the formula I
wherein R
1
to R
6
, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.